Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA.
University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
Gene. 2022 Jul 1;830:146513. doi: 10.1016/j.gene.2022.146513. Epub 2022 Apr 18.
A progressive neurological disorder was identified in purebred Dalmatian dogs. The disease is characterized by anxiety, pacing and circling, hypersensitivity, cognitive decline, sleep disturbance, loss of coordination, loss of control over urination and defecation, and visual impairment. Neurological signs first became apparent when the dogs were approximately 18 months of age and progressed slowly. Two affected littermates were euthanized at approximately 7 years, 5 months and 8 years, 2 months of age due to the severity of neurological impairment. The mother of the affected dogs and four other relatives exhibited milder, later-onset neurological signs. Pronounced accumulations of autofluorescent intracellular inclusions were found in cerebral cortex, cerebellum, optic nerve, and cardiac muscle of the affected dogs. These inclusions co-localized with immunolabeling of the lysosomal marker protein LAMP2 and bound antibodies to mitochondrial ATPase subunit c, indicating that the dogs suffered from a lysosomal storage disease with similarities to the neuronal ceroid lipofuscinoses. Ultrastructural analysis indicated that the storage bodies were surrounded by a single-layer membrane, but the storage granules were distinct from those reported for other lysosomal storage diseases. Whole genome sequences, generated with DNA from the two euthanized Dalmatians, both contained a rare, homozygous single-base deletion and reading-frame shift in CNP which encodes the enzyme CNPase (EC 3.1.4.37). The late-onset disease was exhibited by five of seven related Dalmatians that were heterozygous for the deletion allele and over 8 years of age, whereas none of 16 age-matched reference-allele homozygotes developed neurologic signs. No CNPase antigen could be detected with immunohistochemical labeling in tissues from the dogs with the earlier-onset disorder. Similar to the later-onset Dalmatians, autofluorescent storage granules were apparent in brain and cardiac tissue from transgenic mice that were nullizygous for Cnp. Based on the clinical signs, the histopathological, immunohistochemical, ultrastructural, and molecular-genetic findings, and the finding that nullizygous Cnp mice accumulate autofluorescent storage granules, we propose that the earlier-onset Dalmatian disorder is a novel lysosomal storage disease that results from a loss-of-function mutation in CNP and that shares features characteristic of the neuronal ceroid lipofuscinoses. That the later-onset disorder occurred only in dogs heterozygous for the CNP deletion variant suggests that this disorder is a result of the variant allele's presence.
一种进行性神经障碍在纯种达尔马提亚犬中被发现。该疾病的特征是焦虑、踱步和转圈、过敏、认知能力下降、睡眠障碍、协调能力丧失、无法控制排尿和排便,以及视力障碍。当这些狗大约 18 个月大时,神经症状首次出现,并缓慢进展。两只受影响的同窝幼崽由于神经损伤的严重程度,在大约 7 岁 5 个月和 8 岁 2 个月时被安乐死。受影响犬的母亲和其他四只亲属表现出较轻、发病较晚的神经症状。在受影响犬的大脑皮层、小脑、视神经和心肌中发现了大量明显的细胞内自荧光包涵体。这些包涵体与溶酶体标记蛋白 LAMP2 的免疫标记物共定位,并与线粒体 ATP 酶亚基 c 的抗体结合,表明这些犬患有溶酶体贮积症,与神经元蜡样脂褐质沉积症相似。超微结构分析表明,这些贮积体被单层膜包围,但贮积颗粒与其他溶酶体贮积症报道的不同。用两只安乐死的达尔马提亚犬的 DNA 生成的全基因组序列均包含 CNP 中罕见的纯合单碱基缺失和阅读框移位,CNP 编码 CNPase(EC 3.1.4.37)。在 7 只相关的达尔马提亚犬中,5 只携带缺失等位基因且年龄超过 8 岁的犬表现出晚发性疾病,而 16 只年龄匹配的参考等位基因纯合子中没有一只出现神经症状。在发病较早的犬的组织中,用免疫组织化学标记无法检测到 CNPase 抗原。与晚发性达尔马提亚犬类似,CNp 基因缺失的转基因小鼠的脑和心脏组织中也出现了自发荧光贮积颗粒。基于临床症状、组织病理学、免疫组织化学、超微结构和分子遗传学发现,以及发现 Cnp 基因缺失的纯合子小鼠会积累自发荧光贮积颗粒,我们提出,发病较早的达尔马提亚犬疾病是一种新型溶酶体贮积症,由 CNP 的功能丧失突变引起,与神经元蜡样脂褐质沉积症的特征相似。只有 CNP 缺失变异的杂合子犬才会发生迟发性疾病,这表明这种疾病是变异等位基因存在的结果。